The discovery of the key roles of IL-17A and IL-17A-producing cells in inflammation, autoimmune diseases, and host defense has led to the experimental targeting of the IL-17A pathway in different animal models as well as in clinical trials in humans (Flierl 2008; Freitas 2009; Chen and Kolls 2017). Here, IL17A is linked to autoimmune disease.